HNGE: revenue up 52%, margins expanded and FY 2026 guidance raised
HNGE reported Q3 revenue up 52% year on year to $235M with a 33% operating margin, and raised its FY 2026 guidance, according to TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
HNGE posted third-quarter revenue up 52% year on year to $235M, according to TradingView. The operating margin reached 33%, and adjusted free cash flow came in at $120M.
The company raised its guidance for fiscal 2026. The source says higher yield and growth in eligible lives supported the outlook. MSK remains the core business, while Migraine and GI are expanding the platform.
The summary was generated by AI and may contain inaccuracies, so readers should check important details against the original source.
why it matters
The combination of fast revenue growth, a high margin, strong cash flow and a raised outlook matters for markets. Results like these tend to draw attention to the company's shares and to the digital health segment as a whole.
market impact
Акции HNGE: сильные результаты и повышение прогноза поддерживают бумагу
- HNGE shares pressure up — raised guidance and strong margins support expectations for the stock
tags
instruments
sources
- HNGE: Revenue grew 52%, margins expanded, and FY guidance rose on stronger yield — TradingView, 2 November 2026 at 23:49 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗